Literature DB >> 12446966

Regulation of amyloid beta-peptide levels by enzymatic degradation.

Atish Mukherjee1, Louis B Hersh.   

Abstract

It is generally accepted that amyloid beta peptides (Abeta) play a significant role in the etiology of Alzheimer's disease. The Abeta peptides are produced by the sequential cleavage of an amyloid precursor protein by a betasecretase followed by cleavage by a gamma secretase. The clearance of beta appears to be due primarily by the action of one or more peptidases. An imbalance between the rate of synthesis and the rate of clearance of Abeta is now considered a possible contributor to the onset of Alzheimer's disease. This review focuses on peptidases that have been proposed to contribute to Abeta catabolism and discusses the evidence for their participation in Abeta peptide clearance in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446966     DOI: 10.3233/jad-2002-4501

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

Review 1.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

Review 2.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

3.  Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.

Authors:  C Y Daniel Lee; Wayne Tse; Jonathan D Smith; Gary E Landreth
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

4.  Insulysin: an allosteric enzyme as a target for Alzheimer's disease.

Authors:  Eun Suk Song; Louis B Hersh
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  The role of microglia in amyloid clearance from the AD brain.

Authors:  C Y Daniel Lee; Gary E Landreth
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

6.  Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain.

Authors:  Xike Qin; Yunling Wang; Hemant K Paudel
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

7.  Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.

Authors:  Bonnie C Miller; Elizabeth A Eckman; Kumar Sambamurti; Nicole Dobbs; K Martin Chow; Christopher B Eckman; Louis B Hersh; Dwain L Thiele
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 8.  Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.

Authors:  J Steven Jacobsen; Peter Reinhart; Menelas N Pangalos
Journal:  NeuroRx       Date:  2005-10

Review 9.  Mechanisms of Abeta clearance and catabolism.

Authors:  Suzanne Y Guénette
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

10.  Neprilysin regulates amyloid Beta peptide levels.

Authors:  Robert A Marr; Hanjun Guan; Edward Rockenstein; Mark Kindy; Fred H Gage; Inder Verma; Eliezer Masliah; Louis B Hersh
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.